ARCHIVES

FDA News: ODAC Clears Photofrin For Microinvasive NSCLC

This article is from The Cancer Letter archive.

Vol. 23 No. 37 | September 26, 1997

Download PDF Visit The Full Archive

Related Articles

As Bristol’s Final Defenses Fall, IVAX Prepares Launch Of Generic Paclitaxel.

October 20, 2000

NCI Outlines Need For $3,873 Billion To Seize Cancer Research Opportunities

October 30, 1998

Breast Treatment Component Will Be Planned for WHI

June 21, 1991

VIB CIDAC contract Extended, No Gaps In CANCERGRAMS

June 15, 1984

FDA Proposes To Require Electronic Submission

May 3, 2002

“Roller-Coaster Budget” For NIH Criticized On Capitol Hill; $1 Billion Cut By FY 2000?

March 17, 1995